# Use of O-arm to place an intrathecal catheter through a bony fusion mass: case report

**Authors:** Francesco Sammartino, Sheital Bavishi, Brian Dalm

PMC · DOI: 10.3389/fresc.2025.1530801 · Frontiers in Rehabilitation Sciences · 2025-05-22

## TL;DR

A new surgical technique using O-arm imaging successfully implanted an intrathecal catheter in a patient with a fused spine, improving spastic dystonia.

## Contribution

Demonstrates the use of O-arm neuronavigation to implant an intrathecal catheter in surgically challenging cases with spinal fusion.

## Key findings

- O-arm–aided neuronavigation enabled successful catheter placement at L5–S1 despite thoracic to lumbar fusion.
- The patient experienced persistent improvement in spastic dystonia and quality of life 22 months post-implantation.
- A multidisciplinary approach can expand ITB therapy to patients with postsurgical spine abnormalities.

## Abstract

Intrathecal baclofen (ITB) delivery is an FDA-approved indication for patients with intractable spasticity. Often, implantation in these patients can be considerably challenging, especially if previous surgical fusion involves the procedure access location.

We present the case of a 27-year-old female with T2 American Spinal Injury Association (ASIA) A spinal cord injury (SCI) and chronic spastic dystonia. She was maximized on oral medications without satisfactory control of her painful muscle spasms and was a candidate for ITB trial, which ultimately failed due to the difficulty of accessing the spinal canal due to extensive pseudoarthrosis secondary to thoracic to lumbar fusion. A decision was made to directly implant the pump in the operative room using O-arm–aided neuronavigation to guide catheter access at L5–S1. Currently, at 22 months of follow-up post-pump implant, ITB delivery has led to persistent improvements in her spastic dystonia and many aspects of quality of life.

The current case indicates that a multidisciplinary approach when considering surgical treatments for medication-refractory spasticity may help expand the indications to large numbers of patients with postsurgical spine abnormalities.

## Linked entities

- **Chemicals:** baclofen (PubChem CID 2284)
- **Diseases:** spinal cord injury (MONDO:0043797)

## Full-text entities

- **Diseases:** Spinal Injury (MESH:D013124), spasticity (MESH:D009128), spastic dystonia (MESH:D004421), pseudoarthrosis (MESH:D011542), muscle spasms (MESH:D013035), SCI (MESH:D013119), spine abnormalities (MESH:D016135)
- **Chemicals:** baclofen (MESH:D001418), ITB (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12137080/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12137080/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12137080/full.md

---
Source: https://tomesphere.com/paper/PMC12137080